CFO
Marksans Pharma Limited
Equibles does not estimate personal net worth.
Jatindra Sharma is recorded as CFO at Marksans Pharma Limited. Jatindra Sharma has spoken on 3 earnings calls across 1 company, most recently for Marksans Pharma Limited on November 5, 2026. Marksans Pharma Limited is classified in the Drug Manufacturers - General industry within the Healthcare sector.
“I will take you through the venture performance for the second quarter, followed by the first half performance. Starting with Q2, total incomes to debt for Rs. 928 crores, registering year-on-year growth of 29.2%.”
“Let me take you through the financial performance for Q1 FY27. Operating revenue for Q1 FY27 stood at Rs. 840.8 crores, up 35.6% year-on-year from Rs. 620 crores in Q1 of FY26.”
“In Q4 of FI26, our operating revenue stood at Rs. 856 crores, an increase of 20.8% year-on-year, compared to Rs. 708 crores in the same quarter last year. Revenue from the U.S. and North America market stood at Rs.”
Marksans Pharma Limited
CFO
Transcript header (unverified)
Marksans Pharma Limited
Drug Manufacturers - General · Healthcare
CFO
Earnings Call for the Quarter Ended September 30, 2026
Marksans Pharma Limited
Earnings Call
Marksans Pharma Limited
Marksans Pharma Limited Q4 FY26 Earnings Conference Call
Marksans Pharma Limited
